Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis
Yu-Zheng Ge,Yi-Dan Wang,Zheng Xu,Lu-Wei Xu,Ya-Ping Wang,Mao-Hong Gu,Ai-Xing Ding,Xian-Bo Zhu,Ran Wu,Wen-Cheng Li,You-Di Xu,Rui-Peng Jia
DOI: https://doi.org/10.1007/s13277-014-1861-9
2014-01-01
Abstract:Interferon gamma (IFN-γ) is a potent proinflammatory cytokine which plays a pivotal role in the antiviral, antiproliferative, and antitumor activities. A T-to-A transition at the position +874 of human IFN-γ gene ( IFNG ) has been reported to influence the secretion of IFN-γ and affect cancer susceptibility. However, results from published studies on the association between IFNG +874 T/A polymorphism and cancer risk are inconclusive or even controversial. In order to derive a more precise estimation of the association, a meta-analysis of 38 eligible studies including 5,630 cases and 6,096 controls was conducted with odds ratio (OR) and its corresponding 95 % confidence interval (95 % CI). Overall, no significant association was detected in allelic model (A allele vs. T allele—OR = 0.96, 95 % CI, 0.86–1.08), homozygote comparison (AA vs. TT—OR = 0.97, 95 % CI, 0.79–1.21), heterozygote comparison (AT vs. TT—OR = 1.03, 95 % CI, 0.87–1.23), dominant model (AA + AT vs. TT—OR = 1.00, 95 % CI, 0.87–1.15), nor recessive model (AA vs. AT + TT—OR = 0.93, 95 % CI, 0.78–1.12). Further subgroup analyses based on ethnicity, cancer types, and Hardy–Weinberg equilibrium status failed to demonstrate any significant relationship except in African population under recessive model (AA vs. AT + TT—OR = 0.68, 95 % CI, 0.47–0.97). In conclusion, the current meta-analysis suggested that IFNG +874 T/A polymorphism may not contribute to cancer susceptibility, and further well-designed studies with large sample size are warranted to validate our conclusion.